IQV - NYSE
IQVIA Holdings Inc.
$182.05
-2.6%IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
At a Glance
Live SnapshotIQVIA Holdings Inc. Profit Bridge
Profitability Analysis
Gross Margin
Moderate margins typical of competitive industries. Monitor for pricing pressure or rising costs.
Operating Margin
Acceptable margins but limited operational leverage. Operating expense control is important.
Net Profit Margin
Moderate profitability with room for improvement. Monitor interest expenses and tax efficiency.
Effective Tax Rate
Moderate tax rate typical for most corporations. Represents standard tax burden on profits.
Profitability Insight
Efficient profit conversion: Minimal margin compression from gross to net indicates lean operations and favorable tax/interest environment.
IQVIA Holdings Inc. Income Statement
IQV • NYSE
| IQVIA Holdings Inc. Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||||||
16.3B | 15.4B | 15B | 14.4B | 13.9B | 11.4B | 11.1B | 10.4B | 9.7B | 6.8B | 5.7B | 5.5B | 5.1B | 4.9B | 4.3B | 3.9B | |
GROSS PROFIT | ||||||||||||||||
(12B) | (10B) | (9.7B) | (9.4B) | (9.2B) | (7.5B) | (7.3B) | (6.7B) | (6.3B) | (4.7B) | (4.1B) | (4B) | (3.8B) | (3.6B) | (3.2B) | (2.8B) | |
4.3B | 5.4B | 5.2B | 5B | 4.6B | 3.9B | 3.8B | 3.7B | 3.4B | 2.1B | 1.6B | 1.5B | 1.3B | 1.2B | 1.1B | 1.1B | |
OPERATING INCOME | ||||||||||||||||
(2B) | (3.2B) | (3.3B) | (3.2B) | (3.2B) | (3.1B) | (3B) | (2.9B) | (2.7B) | (1.5B) | (975M) | (911M) | (874.6M) | (836.5M) | (796.7M) | (724.2M) | |
(2B) | (2B) | (2.1B) | (2.1B) | (2B) | (1.8B) | (1.7B) | (1.7B) | (1.6B) | (1B) | (921M) | (882.3M) | (830.2M) | (817.8M) | (762.3M) | (698.4M) | |
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (3.3M) | (0.0) | (5M) | (10.4M) | (0.0) | (0.0) | |
2.3B | 2.2B | 2B | 1.8B | 1.4B | 731M | 777M | 741M | 719M | 642M | 646.6M | 590.4M | 462.3M | 396.4M | 345.3M | 395M | |
PRE-TAX INCOME | ||||||||||||||||
(729M) | (670M) | (672M) | (416M) | (375M) | (416M) | (447M) | (414M) | (346M) | (144M) | (101.8M) | (100.6M) | (123.5M) | (134.4M) | (109.1M) | (141.4M) | |
-684M | -623M | -636M | -403M | -369M | -410M | -438M | -406M | -339M | -140M | -97M | -97M | -119.6M | -131.3M | -105.1M | -137.6M | |
(0.0) | (1.2B) | (1.2B) | (1.2B) | (1.3B) | (1.3B) | (1.3B) | (1.2B) | (1.1B) | (475M) | (160M) | (130M) | (14.1M) | (18.7M) | (34.4M) | (25.8M) | |
-674M | -533M | -518M | -448M | -259M | -351M | -434M | -398M | -361M | -164M | -99M | -89M | -139.2M | -145.2M | -126.1M | -153.3M | |
1.6B | 1.7B | 1.5B | 1.4B | 1.1B | 380M | 343M | 343M | 304M | 412M | 547M | 506M | 323.1M | 270M | 255.4M | 241.7M | |
NET INCOME | ||||||||||||||||
(252M) | (296M) | (101M) | (260M) | (163M) | (72M) | (116M) | (59M) | -987M | (345M) | (159M) | (150.1M) | (96M) | (93.4M) | (15.1M) | (77.6M) | |
1.4B | 1.4B | 1.4B | 1.1B | 966M | 279M | 191M | 259M | 1.3B | 115M | 387.2M | 356.4M | 226.6M | 177.5M | 241.8M | 160.6M |
SEC Filings
IQV - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | June 03, 2026 | June 03, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 07, 2026 | May 07, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 05, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 05, 2026 | May 05, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 23, 2026 | April 23, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | February 27, 2026 | April 23, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 17, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 05, 2026 | February 05, 2026 | 2026 | |
8-K 8-K 2025 N/A | December 09, 2025 | December 09, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 05, 2025 | November 05, 2025 | 2025 |
Related Guides
Continue your IQV research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.